EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chronic pelvic pain among transgender men and gender diverse adults assigned female at birth

Diana M Tordoff iD, Mitchell R Lunn, Annesa Flentje, Diana Atashroo, Bertha Chen, Zubin Dastur, Micah E Lubensky, Matthew Capriotti, Juno Obedin-Maliver

Andrology · 2025

DOI: 10.1111/andr.13703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, 2025. Verfasst von Diana M Tordoff und 8 weiteren Autor:innen. Beteiligte Einrichtung: The PRIDE Study/PRIDEnet, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Transgender Persons, Pelvic Pain, Testosterone, Chronic Pain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDA NIH HHS, Stanford University School of Medicine Department of Obstetrics and Gynecology, National Institute of Diabetes, Digestive, and Kidney Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are limited data on pelvic pain among transgender men and gender diverse people, and the impact of testosterone on pelvic pain is poorly understood.

Objective

Characterize the prevalence and correlates of chronic pelvic pain (CPP) among transgender men and gender diverse people and examine the association between testosterone use and CPP. Materials and methods We used 2020–2022 data from The Population Research in Identity and Disparities for Equality (PRIDE) Study, an online prospective cohort study of sexual and gender minority adults in the United States, to conduct complementary cross‐sectional and longitudinal analyses. Our primary outcome was self‐reported CPP lasting 3 months or longer measured using the Michigan Body Map.

Results

Among 2579 transgender men and gender diverse people assigned female at birth included in our sample, 457 (18%) reported CPP. CPP correlates included: inflammatory bowel disease, irritable bowel syndrome (IBS), kidney stones, pelvic inflammatory disease, polycystic ovary syndrome (PCOS), uterine fibroids, current hormonal intrauterine device use, prior pregnancy, vaginal delivery, hysterectomy, and oophorectomy. Individuals with CPP reported a high prevalence of IBS (37%), PCOS (20%), uterine fibroids (9%), post‐traumatic stress disorder (51%), and severe depression and anxiety symptoms (42% and 25%, respectively). Current testosterone use was associated with a 21% lower prevalence of CPP (adjusted prevalence ratio (aPR) 0.79, 95% confidence interval [CI]: 0.65–0.96). In longitudinal analyses ( N = 79), 15 (19%) participants reported any CPP after initiating testosterone: eight (56%) of whom reported CPP prior to testosterone initiation, and seven (47%) who reported new‐onset CPP. Discussion and conclusions The relationship between CPP and testosterone is complex. Although testosterone use was associated with a lower prevalence of CPP, some transgender and gender diverse individuals experienced new‐onset pelvic pain after testosterone initiation. Given the significant impact that CPP can have on mental health and quality of life, future research must examine the role of testosterone in specific underlying etiologies of CPP and identify potential therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsPelvic PainTestosteroneChronic PainHumansAdultMaleFemaleProspective StudiesCross-Sectional StudiesLongitudinal StudiesPrevalenceMiddle AgedYoung AdultUnited States

Stichwörter der Autor:innen

chronic pelvic paingender‐affirming caretestosteronetransgender

Substanzen

Testosterone

Autor:innen und Institutionen

  • The PRIDE Study/PRIDEnet, Stanford University School of Medicine, Palo Alto, California, USA.
  • Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
  • Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, California, USA.
  • Department of Community Health Systems, School of Nursing, University of California San Francisco, San Francisco, California, USA.
  • Alliance Health Project, Department of Psychiatry, School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Department of Obstetrics and Gynecology, Stanford University School of Medicine, Palo Alto, California, USA.

ORCID-Profile: Diana M Tordoff

Förderung

  • NIDA NIH HHS
  • Stanford University School of Medicine Department of Obstetrics and Gynecology
  • National Institute of Diabetes, Digestive, and Kidney Disorders
  • NIDDK NIH HHS
  • NIH HHS
  • (PCORI) Award
  • Patient-Centered Outcomes Research Institute
  • National Institutes of Health

Zitieren

APA

Tordoff, D. M., Lunn, M. R., Flentje, A., Atashroo, D., Chen, B., Dastur, Z., Lubensky, M. E., Capriotti, M., & Obedin-Maliver, J. (2025). Chronic pelvic pain among transgender men and gender diverse adults assigned female at birth. Andrology. https://doi.org/10.1111/andr.13703

Vancouver

Tordoff DM, Lunn MR, Flentje A, Atashroo D, Chen B, Dastur Z, et al. Chronic pelvic pain among transgender men and gender diverse adults assigned female at birth. Andrology. 2025. doi:10.1111/andr.13703

BibTeX
@article{Tordoff2025,
  author = {Tordoff, Diana M and Lunn, Mitchell R and Flentje, Annesa and Atashroo, Diana and Chen, Bertha and Dastur, Zubin and Lubensky, Micah E and Capriotti, Matthew and Obedin-Maliver, Juno},
  title = {Chronic pelvic pain among transgender men and gender diverse adults assigned female at birth},
  journal = {Andrology},
  year = {2025},
  doi = {10.1111/andr.13703}
}
Kostenlos starten →